In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations.
HealthDay News — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
The move would cut costs for Medicare and save beneficiaries millions of dollars, according to an article in The New York Times.
Under a demonstration project in half the country, Medicare would create and use an “international pricing index” to decide how much to pay for drugs covered by Part B of Medicare.
Continue Reading
A recently released study by the U.S. Department of Health and Human Services revealed that Medicare paid 80 percent more than other advanced industrial countries for some of the most expensive prescription medicines, The Times reported.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. Read an unlimited amount by logging in or registering at no cost.
{{login-button}} {{register-button}}
Get the most out of Cardiology Advisor.
Register for free and enjoy unlimited access to:
- Clinical News
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.